Mammography serves as the primary screening tool for detecting breast cancer, and clinical breast examination serves as an additional low-risk technique.
There are known socioeconomic disparities in screening accessibility that correlate with breast cancer mortality and tumor stage at diagnosis.
Identifying patient barriers and sentiments is a vital step in increasing compliance rates amongst vulnerable populations.
